Skip to content

Article image
Differential Expression Analysis

Overview

Differential expression (DE) analysis is the statistical core of transcriptomics, determining which genes show meaningful expression changes between experimental conditions. Whether comparing treated versus untreated cells, tumor versus normal tissue, or time-course samples, DE analysis transforms raw count data into biological insight. The challenge lies in distinguishing true biological signals from technical noise while accounting for the multiple testing burden inherent in genome-wide measurements. Modern DE methods use sophisticated statistical models that have been benchmarked extensively on real and simulated datasets.

Methods

DE analysis typically starts with a count matrix of reads per gene per sample. Normalization methods (TMM, RLE, or quantile normalization) adjust for library size and compositional biases. Popular tools include DESeq2, which models counts with a negative binomial distribution and uses shrinkage estimation for dispersion; edgeR, which uses empirical Bayes methods; and limma-voom, which applies linear modeling to log-transformed counts transformed with precision weights. For non-model organisms or experiments without [a reference genome, tools like Sailfish or Kallisto perform alignment-free quantification. Results are summarized as log2 fold changes and adjusted p-values (Benjamini-Hochberg correction). Principal component analysis (PCA) and heatmaps provide global views of expression patterns.

Applications

DE analysis is central to virtually every transcriptomics study. It identifies biomarkers for disease diagnosis and prognosis, reveals drug mechanisms of action, and characterizes cellular responses to environmental stimuli. In clinical settings, DE analysis of patient biopsies can stratify cancers for targeted therapy. The method is closely related to RT-PCR validation experiments, which confirm candidate genes, and builds upon DNA microarrays and gene expression techniques. DE results also power gene set enrichment analysis (GSEA) to identify affected pathways and functional categories.